Bhagiradha Chemicals achieved record consolidated revenue of ₹535.94 crore in FY2025-26, a 21.67% increase. The company also recommended a dividend of ₹0.15 per share, signalling growth and shareholder returns.
Bhagiradha Chemicals Posts Record Revenue, Eyes Further Growth
Bhagiradha Chemicals & Industries Ltd. has reported its highest-ever consolidated revenue of ₹535.94 crore for the fiscal year 2025-26. This marks a significant year-on-year growth of 21.67% from ₹440.47 crore in the previous fiscal.
Reader Takeaway: Record revenue growth driven by new facility; ongoing geopolitical risks pose a watch point.
What just happened
Consolidated revenue reached ₹535.94 crore in FY2025-26, up from ₹440.47 crore in FY2024-25. Consolidated profit after tax (PAT) also saw an increase to ₹18.17 crore from ₹13.86 crore. The company recommended a final dividend of ₹0.15 per equity share (15%).
Why this matters
This record revenue highlights the company's successful expansion and operational improvements, particularly with its new facility in Karnataka contributing to capacity. The recommended dividend signals a commitment to returning value to shareholders.
The backstory
Bhagiradha Chemicals transitioned from a single-plant operation to a two-plant enterprise with the commencement of commercial production at its subsidiary, Bheema Fine Chemicals, in Kadechur, Karnataka, on March 27, 2024. The Kadechur facility operated at approximately 35% capacity utilization in FY2025-26.
What changes now
The company is embarking on Phase II of the Kadechur project, involving an estimated ₹400 crore investment, targeted for completion by Q2 FY2027-28. Management indicates a shift from capacity building to value creation, with a target of approximately 3.5 times growth in consolidated revenue over the next four to five years.
Risks to watch
Geopolitical risks, including the US-Iran conflict, could impact energy costs and supply chains. The sector also faces headwinds from excess international inventory, subdued export demand, and pricing pressure from Chinese suppliers.
Peer comparison
While specific peer financial data for FY2025-26 isn't provided in the filing, the growth in revenue and PAT suggests Bhagiradha Chemicals is performing well against industry challenges.
Context metrics (time-bound)
Consolidated Revenue FY2025-26: ₹535.94 crore (up 21.67% YoY)
Consolidated PAT FY2025-26: ₹18.17 crore (up from ₹13.86 crore)
Bheema Fine Chemicals Capacity Utilization FY2025-26: ~35%
What to track next
Investors should monitor the ramp-up in capacity utilization at the Bheema facility and the progress of the Phase II expansion plans. Navigating geopolitical and industry-specific headwinds will also be crucial.